Status:
COMPLETED
Medical Chart Review of Patients on Long-term Treatment With Long-acting Injectable Risperidone
Lead Sponsor:
Johnson & Johnson Taiwan Ltd
Conditions:
Schizophrenia
Schizoaffective Disorder
Eligibility:
All Genders
Brief Summary
The purpose of the study is to evaluate the characteristics, clinical responses, and safety issues of patients receiving long-term treatment of Risperidone long-acting injectable. The goal is to evalu...
Detailed Description
This is an Observational, retrospective study on the use of Risperidone long-acting injectable. The purpose of the study is to evaluate the characteristics, clinical responses, and safety issues of pa...
Eligibility Criteria
Inclusion
- Diagnosis of Schizophrenia or Schizoaffective disorder by DSM-IV-TR criteria
- Patients who used to be treated with Risperidone long-acting injectable regularly for at least 3 months
- Patients whose medical charts or other medical records are available
Exclusion
- None
Key Trial Info
Start Date :
January 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2007
Estimated Enrollment :
342 Patients enrolled
Trial Details
Trial ID
NCT00644852
Start Date
January 1 2007
End Date
September 1 2007
Last Update
May 23 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.